NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
Neoadjuvant chemotherapy (NACT) in breast cancer has undergone continuous evolution over the last few decades to establish its role in the combined modality management of these tumors. The process of evolution is still far from over. Many questions are still lurking in the minds of oncologists treat...
Saved in:
| Main Authors: | Raut Nirmal, Chordiya Nilesh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2010-03-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2010;volume=31;issue=1;spage=8;epage=17;aulast=Raut |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preoperative Hormone Therapy in the Treatment of Breast Cancer: What Do We Know So Far?
by: V. V. Vorotnikov, et al.
Published: (2022-10-01) -
The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
by: Masataka Shimonosono, et al.
Published: (2025-07-01) -
Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
by: Nicole M. Melchior, et al.
Published: (2020-04-01) -
Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population‐Based Large Cohort Study
by: Lixi Li, et al.
Published: (2025-05-01) -
The Impact of Neoadjuvant versus Adjuvant Chemotherapy on Survival Outcomes in Locally Advanced Breast Cancer
by: Farhad Ghasemi, et al.
Published: (2024-10-01)